Literature DB >> 6290291

Effects of vitamin D3 metabolites on production of prolactin and growth hormone in rat pituitary cells.

E Haug, J I Pedersen, K M Gautvik.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6290291     DOI: 10.1016/0303-7207(82)90041-7

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


× No keyword cloud information.
  7 in total

1.  Glucocorticoids antagonize induction of prolactin-gene expression by calcitriol in rat pituitary tumour cells.

Authors:  J D Wark; V Gurtler
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

2.  TSH levels are associated with vitamin D status and seasonality in an adult population of euthyroid adults.

Authors:  I Barchetta; M G Baroni; F Leonetti; M De Bernardinis; L Bertoccini; M Fontana; E Mazzei; A Fraioli; M G Cavallo
Journal:  Clin Exp Med       Date:  2014-06-13       Impact factor: 3.984

3.  Effects of vitamin D3 metabolites on thyrotropin secretion from rat pituitary cells in culture.

Authors:  K Törnquist; L Forss; C Lamberg-Allardt
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

4.  Steroid inhibition of calcitriol-induced prolactin production in GH4C1 cells. Specificity and sensitivity.

Authors:  J D Wark; V Gurtler
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

5.  Culture requirements for optimal expression of 1 alpha,25-dihydroxyvitamin D3-enhanced thyrotropin secretion.

Authors:  M C d'Emden; J D Wark
Journal:  In Vitro Cell Dev Biol       Date:  1991-03

6.  Effect of 1,25-dihydroxyvitamin D3 and nifedipine on prolactin release in normal man.

Authors:  D Verbeelen; L Vanhaelst; M Fuss; A C Van Steirteghem
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

7.  Serum vitamin D metabolites do not change in response to intravenous injection of thyrotropin releasing hormone (TRH) and growth hormone releasing factor (GHRF 1-44) in children.

Authors:  R Rosskamp; S Issa; W Burmeister
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.